Product NDC: | 55390-101 |
Proprietary Name: | Terbutaline Sulfate |
Non Proprietary Name: | Terbutaline Sulfate |
Active Ingredient(s): | 1 mg/mL & nbsp; Terbutaline Sulfate |
Administration Route(s): | SUBCUTANEOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55390-101 |
Labeler Name: | Bedford Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076770 |
Marketing Category: | ANDA |
Start Marketing Date: | 20040428 |
Package NDC: | 55390-101-10 |
Package Description: | 10 VIAL in 1 BOX (55390-101-10) > 1 mL in 1 VIAL |
NDC Code | 55390-101-10 |
Proprietary Name | Terbutaline Sulfate |
Package Description | 10 VIAL in 1 BOX (55390-101-10) > 1 mL in 1 VIAL |
Product NDC | 55390-101 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Terbutaline Sulfate |
Dosage Form Name | INJECTION |
Route Name | SUBCUTANEOUS |
Start Marketing Date | 20040428 |
Marketing Category Name | ANDA |
Labeler Name | Bedford Laboratories |
Substance Name | TERBUTALINE SULFATE |
Strength Number | 1 |
Strength Unit | mg/mL |
Pharmaceutical Classes |